Scott A Canute's Net Worth

$25.4 Million

Estimate Recalculated May 19, 2025 03:11PM EST

Who is Scott A Canute?

Scott A Canute has an estimated net worth of $25.4 Million. This is based on reported shares across multiple companies, which include GENZYME CORP, IMMUNOMEDICS INC, LILLY ELI & CO, Flexion Therapeutics Inc, Oncobiologics, Inc., PROTEON THERAPEUTICS INC, Akebia Therapeutics, Inc., and Oncorus, Inc..

SEC CIK

Scott A Canute's CIK is 0001303416

Past Insider Trading and Trends

2016 was Scott A Canute's most active year for acquiring shares with 9 total transactions. Scott A Canute's most active month to acquire stocks was the month of May. 2005 was Scott A Canute's most active year for disposing of shares, totalling 10 transactions. Scott A Canute's most active month to dispose stocks was the month of October. 2010 saw Scott A Canute paying a total of $5,063,480.00 for 117,750 shares, this is the most they've acquired in one year. In 2011 Scott A Canute cashed out on 142,750 shares for a total of $6,913,480.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

GENZYME CORP No price found

Executive VP

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$74.00
-$1,850,000.00
0
Apr 4
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Mar 15
Form 3
—
0
—
—
0
No matching records found

IMMUNOMEDICS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-13.52K
—
—
0
Oct 23
Form 4
+27.51%
3.72K
—
—
17.23K
Jun 18
Form 4
+251.16%
9.67K
—
—
13.52K
Jun 7
Form 4
—
0
—
—
0
Mar 5 - Mar 8
Form 4
∞
3.85K
—
—
3.85K
Apr 2
Form 4
—
0
—
—
0
Jul 3
Form 3
—
0
—
—
0
No matching records found

LILLY ELI & CO (LLY) Snapshot price: $900.9999

President, Mfg. Operations

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-12.63%
-3.67K
$54.12
-$198,512.16
25.37K
Feb 1
Form 4
+148.59%
17.36K
$52.86
$917,385.30
29.04K
Jan 17
Form 4
—
0
—
—
0
Feb 10
Form 4
∞
11.68K
$57.04
$666,227.20
11.68K
Jan 20
Form 4
+15.64%
2.8K
$40.20
-$7,964.00
20.7K
Aug 10 - Aug 16
Form 4/A
—
0
—
—
0
Aug 3
Form 4
+52.90%
2.09K
$41.01
-$51,685.92
6.04K
Aug 3
Form 4
-18.98%
-926.00
$58.90
-$54,541.40
3.95K
May 23
Form 4
—
0
—
—
0
Feb 11
Form 4
+62.63%
1.88K
$56.79
$106,708.41
4.88K
Jan 14
Form 3
—
0
—
—
0
No matching records found

Flexion Therapeutics Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-9.00K
$8.50
-$76,500.00
0
Nov 19
Form 4
+100.00%
4.5K
—
—
9K
Jun 24
Form 4
∞
4.5K
—
—
4.5K
Jun 10
Form 4
—
0
—
—
0
Jun 19
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Jun 22
Form 4/A
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Mar 4
Form 3
—
0
—
—
0
No matching records found

Oncobiologics, Inc. (OTLK) Snapshot price: $7.95

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 26
Form 4
—
0
—
—
0
Dec 22
Form 4
+30.39%
57.41K
—
—
246.34K
Nov 28
Form 4
—
0
—
—
188.93K
Nov 9
Form 4
+80.73%
58.5K
—
—
130.96K
May 18
Form 3
—
0
—
—
0
No matching records found